Bringing the fundamentals into focus…
Back to Prelude Therapeutics Incorporated
How Prelude Therapeutics Incorporated stacks up
PRLD · against 351 other Healthcare companies of similar size
Overall
42/ 100
Below the middle of the pack.
Ranked #190 of 352 · scores higher than 44% of peers
Bars: peers in each 10-point band of the overall score68 peers with an overall score of 40–49, including PRLD · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around PRLD| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.9B HKD (≈$365M) | 84 | 99 | 63 | 86 | 0 / 2 | |
| 3 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 5 | 433M USD | 81 | 96 | 99 | 99 | 2 / 2 | |
| 190 | 2.8B CNY (≈$392M) | 42 | 32 | 32 | 45 | 1 / 2 | |
| 190 | 14.9B TWD (≈$462M) | 42 | 8 | 33 | 27 | 0 / 2 | |
| 190 | 6.2B TWD (≈$193M) | 42 | 8 | 90 | 4 | 1 / 2 | |
| 190 | 560M USD | 42 | 8 | — | 21 | 0 / 2 | |
| 190 | 302M USD | 42 | 8 | 90 | 10 | 1 / 2 | |
| 190 | 304M EUR (≈$334M) | 42 | 50 | 21 | 49 | 1 / 2 | |
| 198 | 7.2B TWD (≈$224M) | 41 | 8 | 99 | 10 | 1 / 2 | |
| 198 | 365M USD | 41 | 8 | — | 21 | 0 / 2 | |
| 198 | 207M USD | 41 | 8 | — | 17 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score